EPO and stage 5 chronic kidney disease: Anemia is one of the most common consequences of advanced chronic kidney disease and end-stage renal disease (ESRD), because renal disease leads to a relative deficiency of EPO that contributes to fatigue, reduced exercise tolerance, and negatively impacts patient quality of life.